A20FMDV2 is a highly selective alphavbeta6 integrin inhibitor with human IC50 values of 3 nM and binds with at least 1000-fold selectivity over other RGD-binding integrins. A20FMDV2 binds to the integrins RGD-binding site and a hypothesized synergy site, induces rapid integrin internalization, and delays post-internalization integrin recycling to the cell surface. A20FMDV2 can be used for the research of pancreatic cancer, breast cancer, colorectal cancer, ovarian cancer, oral squamous cell carcinoma[1][2].
Molecular Weight:
2163.48
Purity:
99.80
CAS Number:
[932699-03-1]
Formula:
C93H163N31O28
Target:
Integrin
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
